Get started
Author

Naomy Kim

Observed name: N.K.D. Kim
ORCID: 0009-0008-7747-514X
Observed ORCID: 0009-0008-7747-514X
OpenAlex ID: A5032317701
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
2018 · S.T. Kim, K.C. Banks, et al. · Annals of Oncology · 106
Novel Biomarkers for Early Detection of Hepatocellular Carcinoma
2024 · Abdelrahman M. Attia, Mohammad Saeid Rezaee-Zavareh, et al. · Diagnostics · 44
PDF
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease
2024 · Jeff Liang, Naomy Kim, et al. · Translational Gastroenterology and Hepatology · 18
Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors
2025 · Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, et al. · Discover Oncology · 11
PDF
Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study
2025 · Amit G. Singal, Ju Dong Yang, et al. · The American Journal of Gastroenterology · 9
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
2024 · Mohammad Saeid Rezaee-Zavareh, Naomy Kim, et al. · Clinical and Molecular Hepatology · 8
PDF
Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics
2024 · Mohammad Saeid Rezaee-Zavareh, Naomy Kim, et al. · Frontiers in Oncology · 6
Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank
2026 · Hyun-Seok Kim, Mohammad Saeid Rezaee-Zavareh, et al. · Clinical Gastroenterology and Hepatology · 1
Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al. · Cancer Research Communications · 1
Clinical outcome after complete response with immunotherapy in hepatocellular carcinoma.
2025 · Pin-Jung Chen, Ioannis Kournoutas, et al. · Journal of Clinical Oncology · 1
Long-Term Prednisone Use Increases Hepatocellular Carcinoma Risk in Autoimmune Hepatitis Cirrhosis: A Retrospective Cohort Study
2025 · Jessica Liu, Rami Hemadeh, et al. · Gastro Hep Advances · 1
Treatment-Stratified Immune–Inflammatory Trajectories and Early Response in Patients with Hepatocellular Carcinoma Receiving Systemic Therapy
2026 · Ashley Kim, Manaf Alsudaney, et al. · Diagnostics
Table 3 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table S1 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table S4 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table S3 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table 2 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table S2 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Table 1 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Data from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Figure S1 from Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis
2026 · Manaf Alsudaney, Ashley Kim, et al.
Complement Proteins and Liver Diseases: A Response to the Correspondence
2024 · Mohammad Saeid Rezaee-Zavareh, Naomy Kim, et al. · Clinical and Molecular Hepatology
PDF
Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study
2023 · Jun Ho Ji, Kwang Min Kim, et al. · Precision and Future Medicine
PDF
Multidimensional genomic analysis of cell-free DNA for early detection of hepatocellular carcinoma
2023 · Ju Dong Yang, Poching Liu, et al. · Journal of Hepatology
Works count: 24
Citation count: 205
H-index: 6
I10-index: 4
Year
Topic
Type